Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 26, 2021; 9(27): 7986-7997
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.7986
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.7986
Table 1 Interactions between the common immunosuppressive medications and the novel therapeutic agents of coronavirus disease 2019 disease
RMD | FAV | CL/HCL | TCZ | LPV/r | |
Prednisone | <-> | <-> | <-> | <-> | ↑ |
Methylprednisone | <-> | <-> | <-> | <-> | ↑ |
Cyclosporine | <-> | <-> | ↑ | ↓ | ↑ |
Tacrolimus | <-> | <-> | ↑ | ↓ | ↑ |
Sirolimus | <-> | <-> | ↑ | ↓ | ↑↓ |
Mycophenolate | <-> | <-> | <-> | <-> | |
Azatguoprine | <-> | <-> | <-> | <-> | <-> |
Anti-thymocyte globulin | <-> | <-> | <-> | <-> | <-> |
Basiliximab | <-> | <-> | <-> | <-> | <-> |
- Citation: Nassar M, Nso N, Ariyaratnam J, Sandhu J, Mohamed M, Baraka B, Ibrahim A, Alfishawy M, Zheng D, Bhangoo H, Soliman KM, Li M, Rizzo V, Daoud A. Coronavirus disease 2019 and renal transplantation. World J Clin Cases 2021; 9(27): 7986-7997
- URL: https://www.wjgnet.com/2307-8960/full/v9/i27/7986.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i27.7986